Trials / Active Not Recruiting
Active Not RecruitingNCT06528821
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality in Acute Coronary Syndromes
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Powerful Medical · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocardiographic findings detected by an automated artificial intelligence (AI) model that can predict coronary blood flow alteration as assessed by the TIMI grade flow at the very moment of the invasive coronary angiography in patients with acute coronary syndromes.
Conditions
- Acute Coronary Syndrome
- STEMI
- Coronary Occlusion
- Coronary Syndrome
- NSTEMI
- NSTEMI - Non-ST Segment Elevation MI
Timeline
- Start date
- 2024-12-10
- Primary completion
- 2026-03-16
- Completion
- 2026-05-16
- First posted
- 2024-07-30
- Last updated
- 2026-03-20
Locations
9 sites across 3 countries: Austria, Belgium, Italy
Source: ClinicalTrials.gov record NCT06528821. Inclusion in this directory is not an endorsement.